| Title : Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study - Rosenstock_2006_Clin.Ther_28_1556 |
| Author(s) : Rosenstock J , Brazg R , Andryuk PJ , Lu K , Stein P |
| Ref : Clin Ther , 28 :1556 , 2006 |
| Abstract : Rosenstock_2006_Clin.Ther_28_1556 |
| ESTHER : Rosenstock_2006_Clin.Ther_28_1556 |
| PubMedSearch : Rosenstock_2006_Clin.Ther_28_1556 |
| PubMedID: 17157112 |
Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P (2006)
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
Clin Ther
28 :1556
Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P (2006)
Clin Ther
28 :1556